Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

Late Plasma Cell Depletion After Thymoglobulin Induction in Kidney Transplant Recipients.

Irure J, Sango C, Segundo DS, Fernández-Fresnedo G, Ruiz JC, Benito-Hernández A, Asensio E, López-Hoyos M, Rodrigo E.

Exp Clin Transplant. 2019 Apr 9. doi: 10.6002/ect.2018.0261. [Epub ahead of print]

2.

Regulatory T-cell Number in Peripheral Blood at 1 Year Posttransplant as Predictor of Long-term Kidney Graft Survival.

San Segundo D, Galván-Espinoza LH, Rodrigo E, Irure J, Ruiz JC, Fernández-Fresnedo G, Riesco L, Bada J, Belmar L, Lopez-Hoyos M.

Transplant Direct. 2019 Feb 8;5(3):e426. doi: 10.1097/TXD.0000000000000871. eCollection 2019 Mar.

3.

Variability of the Mammalian Target of Rapamycin Inhibitors Is Correlated With Long-Term Renal Graft Survival.

Valero R, Sanchez-Fructuoso A, Rodrigo E, Belmar L, Cos MA, Perez-Flores I, Delgado J, San Millan JCR.

Transplant Proc. 2019 Mar;51(2):341-343. doi: 10.1016/j.transproceed.2018.08.016. Epub 2018 Sep 5.

PMID:
30879537
4.

Static Cold Storage vs Ex Vivo Machine Perfusion: Results From a Comparative Study on Renal Transplant Outcome in a Controlled Donation After Circulatory Death Program.

Arlaban M, Barreda P, Ballesteros MA, Rodrigo E, Suberviola B, Valero R, Miñambres E, Ruiz-San Millán JC.

Transplant Proc. 2019 Mar;51(2):311-313. doi: 10.1016/j.transproceed.2018.12.010. Epub 2018 Dec 12.

PMID:
30879530
5.

Simple electrochemical reduction of nitrones to amines.

Rodrigo E, Waldvogel SR.

Chem Sci. 2018 Dec 11;10(7):2044-2047. doi: 10.1039/c8sc04337j. eCollection 2019 Feb 21.

6.

A proliferation-inducing ligand increase precedes IgA nephropathy recurrence in kidney transplant recipients.

Martín-Penagos L, Benito-Hernández A, San Segundo D, Sango C, Azueta A, Gómez-Román J, Fernández-Fresnedo G, López-Hoyos M, Ruiz JC, Rodrigo E.

Clin Transplant. 2019 Apr;33(4):e13502. doi: 10.1111/ctr.13502. Epub 2019 Mar 11.

PMID:
30776158
7.

Anti-perlecan antibodies and acute humoral rejection in hypersensitized patients without forbidden HLA specificities after kidney transplantation.

Riesco L, Irure J, Rodrigo E, Guiral S, Ruiz JC, Gómez J, López-Hoyos M, San Segundo D.

Transpl Immunol. 2019 Feb;52:53-56. doi: 10.1016/j.trim.2018.11.002. Epub 2018 Nov 17.

PMID:
30458294
8.

Can we manage without biopsy in membranous nephropathy with positive anti-PLA2R antibodies?

Ruiz Martínez L, Fernández Fresnedo G, Rodrigo E, Heras M.

Nefrologia. 2019 May - Jun;39(3):311-312. doi: 10.1016/j.nefro.2018.07.003. Epub 2018 Sep 19. English, Spanish. No abstract available.

9.

A Protocol To Transform Sulfones into Nitrones and Aldehydes.

Rodrigo E, Alonso I, Cid MB.

Org Lett. 2018 Sep 21;20(18):5789-5793. doi: 10.1021/acs.orglett.8b02483. Epub 2018 Sep 12.

PMID:
30207472
10.

Role of genetic and electrolyte abnormalities in prolonged QTc interval and sudden cardiac death in end-stage renal disease patients.

Coll M, Ferrer-Costa C, Pich S, Allegue C, Rodrigo E, Fernández-Fresnedo G, Barreda P, Mates J, Martinez de Francisco AL, Ortega I, Iglesias A, Campuzano O, Salas E, Arias M, Brugada R.

PLoS One. 2018 Jul 18;13(7):e0200756. doi: 10.1371/journal.pone.0200756. eCollection 2018.

11.

Modern Electrochemical Aspects for the Synthesis of Value-Added Organic Products.

Möhle S, Zirbes M, Rodrigo E, Gieshoff T, Wiebe A, Waldvogel SR.

Angew Chem Int Ed Engl. 2018 May 22;57(21):6018-6041. doi: 10.1002/anie.201712732. Epub 2018 Apr 19. Review.

12.

Electrifying Organic Synthesis.

Wiebe A, Gieshoff T, Möhle S, Rodrigo E, Zirbes M, Waldvogel SR.

Angew Chem Int Ed Engl. 2018 May 14;57(20):5594-5619. doi: 10.1002/anie.201711060. Epub 2018 Mar 7. Review.

13.

A clinical-genetic approach to assessing cardiovascular risk in patients with CKD.

Rodrigo E, Pich S, Subirana I, Fernandez-Fresnedo G, Barreda P, Ferrer-Costa C, M de Francisco ÁL, Salas E, Elosua R, Arias M.

Clin Kidney J. 2017 Oct;10(5):672-678. doi: 10.1093/ckj/sfx039. Epub 2017 Jun 22.

14.

Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A multicenter, prospective, randomized, double-blind clinical trial.

Moreso F, Crespo M, Ruiz JC, Torres A, Gutierrez-Dalmau A, Osuna A, Perelló M, Pascual J, Torres IB, Redondo-Pachón D, Rodrigo E, Lopez-Hoyos M, Seron D.

Am J Transplant. 2018 Apr;18(4):927-935. doi: 10.1111/ajt.14520. Epub 2017 Oct 24.

15.

Paraneoplastic pauci-immune glomerulonephritis in a patient with lung carcinoma.

Belmar L, López-Hoyos M, Irure J, Rodrigo E, Martin de Francisco ÁL, Fernández-Fresnedo G.

Nefrologia. 2017 Sep - Oct;37(5):539-541. doi: 10.1016/j.nefro.2016.10.012. English, Spanish. No abstract available.

16.

Hemophagocytic Lymphohistiocytosis: A Dangerous Intruder in Pediatric Acute Lymphoblastic Leukemia.

Martínez-Romera I, Villa M, Areal P, Rodrigo E, Herrero B, López-Ibor B.

J Pediatr Hematol Oncol. 2018 Mar;40(2):e108-e110. doi: 10.1097/MPH.0000000000000932.

PMID:
28859036
17.

An internally validated new clinical and inflammation-based prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenib.

Diaz-Beveridge R, Bruixola G, Lorente D, Caballero J, Rodrigo E, Segura Á, Akhoundova D, Giménez A, Aparicio J.

Clin Transl Oncol. 2018 Mar;20(3):322-329. doi: 10.1007/s12094-017-1720-4. Epub 2017 Aug 11.

PMID:
28801777
18.

Association between recurrence of acute kidney injury and mortality in intensive care unit patients with severe sepsis.

Rodrigo E, Suberviola B, Santibáñez M, Belmar L, Castellanos Á, Heras M, Rodríguez-Borregán JC, de Francisco ALM, Ronco C.

J Intensive Care. 2017 May 22;5:28. doi: 10.1186/s40560-017-0225-0. eCollection 2017.

19.

Subclinical Antibody-Mediated Rejection.

Arias M, Serón D, Herrero I, Rush DN, Wiebe C, Nickerson PW, Ussetti P, Rodrigo E, de Cos MA.

Transplantation. 2017 Jun;101(6S Suppl 1):S1-S18. doi: 10.1097/TP.0000000000001735. Review. No abstract available.

PMID:
28538291
20.

Association between exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prior to septic shock and acute kidney injury.

Suberviola B, Rodrigo E, González-Castro A, Serrano M, Heras M, Castellanos-Ortega Á.

Med Intensiva. 2017 Jan - Feb;41(1):21-27. doi: 10.1016/j.medin.2016.07.010. Epub 2016 Oct 27. English, Spanish.

21.

Intermediate steroid withdrawal after renal transplantation and anti-HLA antibodies (HLA-Abs) development.

Monfá E, San Segundo D, San Millán JCR, Sanabria J, Albines Z, Rodrigo E, Romón I, Asensio E, Arias M, López-Hoyos M.

Nefrologia. 2017 Jul - Aug;37(4):415-422. doi: 10.1016/j.nefro.2017.02.002. Epub 2017 Mar 19. English, Spanish.

22.

Improvement in the definition of anti-HLA antibody profile in highly sensitized patients.

Irure J, Asensio E, Rodrigo E, Romón Í, Gómez J, Arias M, López-Hoyos M, San Segundo D.

PLoS One. 2017 Feb 3;12(2):e0171463. doi: 10.1371/journal.pone.0171463. eCollection 2017.

23.

Improving the Outcomes of Organs Obtained From Controlled Donation After Circulatory Death Donors Using Abdominal Normothermic Regional Perfusion.

Miñambres E, Suberviola B, Dominguez-Gil B, Rodrigo E, Ruiz-San Millan JC, Rodríguez-San Juan JC, Ballesteros MA.

Am J Transplant. 2017 Aug;17(8):2165-2172. doi: 10.1111/ajt.14214. Epub 2017 Mar 28.

24.

Assessment of Kidney Graft Function Evolution Measured by Creatinine and Cystatin C.

Ramos-Barron MA, Hernandez Bejarano I, Rodrigo E, Cruz Iglesias E, Benito Hernandez A, Agueros Blanco C, Morales Martin AI, Prieto Vicente M, Lopez Hernandez F, Arias M, Gomez-Alamillo C.

Transplant Proc. 2016 Nov;48(9):2913-2916. doi: 10.1016/j.transproceed.2016.09.027.

PMID:
27932106
25.

B-Cell-Activating Factor Levels Are Associated With Antibody-Mediated Histological Damage in Kidney Transplantation.

Sango C, Merino D, San Segundo D, Rodrigo E, Lopez-Hoyos M, Benito A, Ángeles Ramos M, Gómez-Román J, Arias M.

Transplant Proc. 2016 Nov;48(9):2910-2912. doi: 10.1016/j.transproceed.2016.09.019.

PMID:
27932105
26.

Antibody-Mediated Rejection in Kidney Transplantation Without Evidence of Anti-HLA Antibodies?

Irure J, López-Hoyos M, Rodrigo E, Gómez-Román J, Ruiz JC, Arias M, San Segundo D.

Transplant Proc. 2016 Nov;48(9):2888-2890. doi: 10.1016/j.transproceed.2016.09.025.

PMID:
27932099
27.

Influence of specific thoracic donor therapy on kidney donation and long-term kidney graft survival.

Ballesteros MA, Duerto Álvarez J, Martín-Penagos L, Rodrigo E, Arias M, Miñambres E.

J Nephrol. 2017 Dec;30(6):869-875. doi: 10.1007/s40620-016-0355-9. Epub 2016 Nov 9.

PMID:
27830458
28.

Expanding the Potential of Heteroaryl Vinyl Sulfones.

Rodrigo E, Alonso I, García Ruano JL, Cid MB.

J Org Chem. 2016 Nov 18;81(22):10887-10899. Epub 2016 Nov 3.

PMID:
27766863
29.

Within-Patient Variability in Tacrolimus Blood Levels Predicts Kidney Graft Loss and Donor-Specific Antibody Development.

Rodrigo E, Segundo DS, Fernández-Fresnedo G, López-Hoyos M, Benito A, Ruiz JC, de Cos MA, Arias M.

Transplantation. 2016 Nov;100(11):2479-2485.

PMID:
26703349
30.

A high sodium intake reduces antiproteinuric response to renin-angiotensin-aldosterone system blockade in kidney transplant recipients.

Monfá E, Rodrigo E, Belmar L, Sango C, Moussa F, Ruiz San Millán JC, Piñera C, Fernández-Fresnedo G, Arias M.

Nefrologia. 2016 Sep - Oct;36(5):545-551. doi: 10.1016/j.nefro.2016.01.018. Epub 2016 Jul 16. English, Spanish.

31.

A comparison of acute kidney injury classification systems in sepsis.

Rodrigo E, Suberviola B, Albines Z, Castellanos Á, Heras M, Rodriguez-Borregán JC, Piñera C, Serrano M, Arias M.

Nefrologia. 2016 Sep - Oct;36(5):530-534. doi: 10.1016/j.nefro.2016.03.021. Epub 2016 Jun 11. English, Spanish.

32.

Different in vitro proliferation and cytokine-production inhibition of memory T-cell subsets after calcineurin and mammalian target of rapamycin inhibitors treatment.

Merino D, San Segundo D, Medina JM, Rodrigo E, Asensio E, Irure J, Fernández-Fresnedo G, Arias MA, López-Hoyos M.

Immunology. 2016 Jun;148(2):206-15. doi: 10.1111/imm.12603. Epub 2016 Mar 29.

33.

High proportion of CD95(+) and CD38(+) in cultured CD8(+) T cells predicts acute rejection and infection, respectively, in kidney recipients.

Mancebo E, Castro MJ, Allende LM, Talayero P, Brunet M, Millán O, Guirado L, López-Hoyos M, San Segundo D, Rodrigo E, Muñoz P, Boix Giner F, Llorente Viñas S, Muro-Amador M, Paz-Artal E.

Transpl Immunol. 2016 Feb;34:33-41. doi: 10.1016/j.trim.2016.01.001. Epub 2016 Jan 7.

PMID:
26773856
34.

Sodium Excretion Pattern at 1 Year After Kidney Transplantation and High Blood Pressure.

Rodrigo E, Monfá E, Albines Z, Serrano M, Fernandez-Fresnedo G, Ruiz JC, Piñera C, Palomar R, Martín-Penagos L, Arias M.

Ann Transplant. 2015 Sep 24;20:569-75. doi: 10.12659/AOT.893862.

35.

Long-Term Mortality among Hospitalized Non-ICU Patients with Acute Kidney Injury Referred to Nephrology.

Ruiz-Criado J, Ramos-Barron MA, Fernandez-Fresnedo G, Rodrigo E, De Francisco AL, Arias M, Gomez-Alamillo C.

Nephron. 2015;131(1):23-33. doi: 10.1159/000437340. Epub 2015 Aug 12.

PMID:
26277844
36.

Multimodality Treatment of Pediatric and Adult Patients With Ewing Sarcoma: A Single-institution Experience.

Diaz-Beveridge R, Lorente D, Torres B, Cañete A, Rodrigo E, Bruixola G, Berlanga P, Reche E, Montalar J, Verdeguer A, Aparicio J.

J Pediatr Hematol Oncol. 2015 Jul;37(5):e278-84. doi: 10.1097/MPH.0000000000000339.

PMID:
25929608
37.

ABCB1 (MDR-1) pharmacogenetics of tacrolimus in renal transplanted patients: a Next Generation Sequencing approach.

Tavira B, Gómez J, Diaz-Corte C, Suarez B, Coronel D, Arias M, López-Larrea C, Iglesias S, Alonso B, Rodrigo E, Coto E.

Clin Chem Lab Med. 2015 Sep 1;53(10):1515-9. doi: 10.1515/cclm-2014-1195.

PMID:
25781547
38.

Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy.

Quintana LF, Blasco M, Seras M, Pérez NS, López-Hoyos M, Villarroel P, Rodrigo E, Viñas O, Ercilla G, Diekmann F, Gómez-Roman JJ, Fernandez-Fresnedo G, Oppenheimer F, Arias M, Campistol JM.

Transplantation. 2015 Aug;99(8):1709-14. doi: 10.1097/TP.0000000000000630.

PMID:
25675198
39.

Number of antihypertensive drugs at 1 year after kidney transplantation.

Kislikova M, Seras M, Monfa E, Rodrigo E, Fernandez-Fresnedo G, Ruiz JC, Arias M.

Transplant Proc. 2015 Jan-Feb;47(1):76-7. doi: 10.1016/j.transproceed.2014.12.009.

PMID:
25645775
40.

Frequencies of circulating B-cell subpopulations before kidney transplantation identify patients at risk of acute rejection.

San Segundo D, Rodrigo E, Kislikova M, Ruiz JC, Fernandez-Fresnedo G, Asensio E, Arias M, Lopez-Hoyos M.

Transplant Proc. 2015 Jan-Feb;47(1):54-6. doi: 10.1016/j.transproceed.2014.12.011.

PMID:
25645769
41.

Strokes in patients on haemodialysis: incidence, onset time and associated factors.

Belmar L, de Francisco AL, Bueno L, Piñera C, Monfá E, Kislikova M, Seras M, Rodrigo E, Arias M.

Nefrologia. 2014 May 21;34(3):347-52. doi: 10.3265/Nefrologia.pre2014.Jan.12298. English, Spanish.

42.

Reduced graphene oxide supported piperazine in aminocatalysis.

Rodrigo E, García Alcubilla B, Sainz R, Fierro JL, Ferritto R, Cid MB.

Chem Commun (Camb). 2014 Jun 14;50(47):6270-3. doi: 10.1039/c4cc02701a. Epub 2014 May 6.

PMID:
24796296
43.

Preoperative inspiratory muscle training to prevent postoperative pulmonary complications in patients undergoing esophageal resection (PREPARE study): study protocol for a randomized controlled trial.

Valkenet K, Trappenburg JC, Gosselink R, Sosef MN, Willms J, Rosman C, Pieters H, Scheepers JJ, de Heus SC, Reynolds JV, Guinan E, Ruurda JP, Rodrigo EH, Nafteux P, Fontaine M, Kouwenhoven EA, Kerkemeyer M, van der Peet DL, Hania SW, van Hillegersberg R, Backx FJ.

Trials. 2014 Apr 27;15:144. doi: 10.1186/1745-6215-15-144.

44.

Predictive factors of allosensitization in renal transplant patients switched from calcineurin to mTOR inhibitors.

Ruiz San Millán JC, López-Hoyos M, Segundo DS, Quintela E, Rodrigo E, Gómez-Alamillo C, Romón I, Arias M.

Transpl Int. 2014 Aug;27(8):847-56. doi: 10.1111/tri.12334. Epub 2014 Jun 17.

45.

Enhanced posttransplant management of patients with diabetes improves patient outcomes.

Keddis MT, El Ters M, Rodrigo E, Dean P, Wohlfahrtova M, Kudva YC, Lorenz EC, Cosio FG.

Kidney Int. 2014 Sep;86(3):610-8. doi: 10.1038/ki.2014.70. Epub 2014 Apr 2.

46.

Organocatalytic Michael addition/intramolecular Julia-Kocienski olefination for the preparation of nitrocyclohexenes.

Rodrigo E, García Ruano JL, Cid MB.

J Org Chem. 2013 Nov 1;78(21):10737-46. doi: 10.1021/jo401686u. Epub 2013 Oct 18.

PMID:
24063759
47.

Identification of the Plasmodium berghei resistance locus 9 linked to survival on chromosome 9.

Bopp SE, Rodrigo E, González-Páez GE, Frazer M, Barnes SW, Valim C, Watson J, Walker JR, Schmedt C, Winzeler EA.

Malar J. 2013 Sep 11;12:316. doi: 10.1186/1475-2875-12-316.

48.

Kidney allograft survival after acute rejection, the value of follow-up biopsies.

El Ters M, Grande JP, Keddis MT, Rodrigo E, Chopra B, Dean PG, Stegall MD, Cosio FG.

Am J Transplant. 2013 Sep;13(9):2334-41. doi: 10.1111/ajt.12370. Epub 2013 Jul 19.

49.

The usefulness of intracellular adenosine-5'-triphosphate measurement in CD4+ cells in renal transplant.

López-Hoyos M, Rodrigo E, Arias M.

Nefrologia. 2013;33(3):381-8. doi: 10.3265/Nefrologia.pre2012.Oct.11540. Epub 2013 Feb 15. Review. English, Spanish.

50.

Kidney Transplantation Group of the Spanish Society of Nephrology.

Pascual J, Cruzado JM, Alonso A, Diekman F, Gallego RJ, Gutiérrez-Dalmau A, Hernández D, Morales JM, Rodrigo E, Zárraga S.

Nefrologia. 2013;33(2):160-3. doi: 10.3265/Nefrologia.pre2013.Feb.11902. English, Spanish. No abstract available.

Supplemental Content

Loading ...
Support Center